Allogeneic ABCB5-positive Stem Cells for Treatment of PAOD
Stopped Very slow recruitment of patients and the current COVID-19 pandemic situation.
Conditions
- Peripheral Arterial Occlusive Disease
Interventions
- BIOLOGICAL: allo-APZ2-PAOD
- DRUG: Placebo
Sponsor
RHEACELL GmbH & Co. KG
Collaborators
- [object Object]
- [object Object]
- [object Object]